XM does not provide services to residents of the United States of America.

Thailand-based Indorama Ventures aims to sell assets, list businesses



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 2-Thailand-based Indorama Ventures aims to sell assets, list businesses</title></head><body>

Adds quote in paragraphs 3, background in paragraphs 7-9

By Chayut Setboonsarng

BANGKOK, March 5 (Reuters) -Thailand-based chemicals company Indorama Ventures (IVL) IVL.BK plans to shift away fromdebt-funded acquisitions and list its businesses to fundgrowth organically, its founder and CEO Aloke Lohia told Reuters on Tuesday.

One of the world's largest petrochemical makers, IVL is in the midst of a "significant pivot" after structural changes in the industry since the pandemic, he said. It aims to lift its earnings before interest, taxes, depreciation, and amortisation (EBIDTA) to $2.1 billion by 2026.

"Now we have the scale. We have the assets. The next phase of IVL is built on organic growth," he said in an interview in his Bangkok office.

The comments come after the company posted its worst financial results in 2023, booking losses of $310 million versus profits of $884 million in the year before.

As part of the pivot, the company will bring down debt by$2.5 billion to around $4.3 billion in 2026, sell off non-core assets worth $1.3 billion, and eliminate six high-cost assets mostly in Europe.

IVL will also list some of itsbusinesses to raise funding to service debt. Lohia said its integrated oxides and derivatives business may be listed "somewhere in the West" while its packaging business may be listed in India or elsewhere in Asia, for a total of $1 billion.

Founded in 1994, Indorama Ventures grew its business with 50 acquisitions in the past two decades with a total enterprise value of $10.9 billion, according to its website.

Forbes ranks the India-born Lohia as Thailand's 17th richest with a net worth of $1.96 billion.

The company, which has more than 140 facilities in 35 countries, produces polyethylene terephthalate (PET), the resin used to make plastic bottles. Another major business is IODs, which have a variety of uses in personal care and agriculture



Editing by Kanupriya Kapoor

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.